论文部分内容阅读
既往研究表明,糖尿病患者支架内再狭窄发生率较高,特别是置入金属裸支架的患者。应用药物预防再狭窄的发生很有必要。本试验旨在验证糖尿病患者经皮冠状动脉介入治疗(PCI)后应用秋水仙素能否减少金属裸支架内再狭
Previous studies have shown that there is a high incidence of restenosis in stents with diabetes, especially in patients with bare metal stents. The application of drugs to prevent the occurrence of restenosis is necessary. The purpose of this study was to examine whether colchicine treatment in diabetic patients after percutaneous coronary intervention (PCI) can reduce the risk of restenosis in bare-metal stents